Palladium-Mediated [2+1]Cycloaddition of Norbornene Derivatives with Ynamides
tained free of charge from The Cambridge Crystallographic
[7] a) C. Cheng, T. Shimo, K. Somekawa, M. Kawaminami,
Tetrahedron Lett. 1997, 38, 9005–9008; b) C. Cheng, T.
Shimo, K. Somekawa, M. Baba, Tetrahedron 1998, 54,
2031–2040; c) Y.-L. Qiu, M. B. Ksebati, R. G. Ptak,
B. Y. Fan, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng,
E. R. Kern, J. C. Drach, J. Zemlicka, J. Med. Chem.
1998, 41, 10–23; d) Y.-L. Qiu, J. Zemlicka, Synthesis
1998, 1447–1452.
Acknowledgements
We thank the CNRS and the ANR (program BLAN07-
1 190839) for funding and the Ministꢀre de l’enseignement
supꢁrieur et de la recherche (A.L. and D.G. Ph.D. grants).
We are grateful to Christophe Chendo and Dr. Valꢁrie Mon-
nier for mass spectrometry analyses and Dr. Michel Giorgi
for X-ray determination (Spectropole, Fꢁdꢁration des Scien-
ces Chimiques de Marseille). We also thank Dr. Nicolas Van-
thuyne for chiral HPLC separation.
[8] M. Limbach, A. Lygin, M. Es-Sayed, A. de Meijere,
Eur. J. Org. Chem. 2009, 1357–1364.
[9] For comprehensive reviews, see: a) G. Evano, A. Coste,
K. Jouvin, Angew. Chem. 2010, 122, 2902–2921; Angew.
Chem. Int. Ed. 2010, 49, 2840–2859; b) K. A. DeKorver,
H. Li, A. G. Lohse, R. Hayashi, Z. Lu, Y. Zhang, R. P.
Hsung, Chem. Rev. 2010, 110, 5064–5106.
[10] a) H. Clavier, K. Le Jeune, I. De Riggi, A. Tenaglia, G.
Buono, Org. Lett. 2011, 13, 308–311; b) T. Achard, A.
Lepronier, Y. Gimbert, H. Clavier, L. Giordano, A. Te-
naglia, G. Buono, Angew. Chem. 2011, 123, 3614–3618;
Angew. Chem. Int. Ed. 2011, 50, 3552–3556; c) A. Tena-
glia, S. Marc, L. Giordano, I. De Riggi, Angew. Chem.
2011, 123, 9228–9231; Angew. Chem. Int. Ed. 2011, 50,
9062–9065; d) H. Clavier, L. Giordano, A. Tenaglia,
Angew. Chem. 2012, 124, 8776–8779; Angew. Chem.
Int. Ed. 2012, 51, 8648–8651.
[11] a) A. Tenaglia, L. Giordano, G. Buono, Org. Lett. 2006,
8, 4315–4318; see also: b) A. Tenaglia, K. Le Jeune, L.
Giordano, G. Buono, Org. Lett. 2011, 13, 636–639.
[12] For reviews on secondary phosphine oxides, see: a) L.
Ackermann, Synthesis 2006, 1557–1571; b) L. Acker-
mann, R. Born, J. H. Spatz, A. Althammer, C. J.
Gschrei, Pure Appl. Chem. 2006, 78, 209–214; c) L. Ac-
kermann, Synlett 2007, 507–526; d) L. Ackermann, in:
Phosphorus Ligands in Asymmetric Catalysis, Vol. 2,
(Ed.: A. Bçrner), Wiley-VCH, Weinheim, 2008,
pp 831–847; e) T. M. Shaikh, C.-M. Weng, F.-E. Hong,
Coord. Chem. Rev. 2012, 256, 771–803.
References
[1] For reviews on the synthesis of MCPs, see: a) A.
Brandi, A. Goti, Chem. Rev. 1998, 98, 589–635; b) G.
Audran, H. Pellissier, Adv. Synth. Catal. 2010, 352,
575–608.
[2] For reviews on synthetic applications of MPCs, see:
a) A. Brandi, S. Cicchi, M. Cordero, A. Goti, Chem.
Rev. 2003, 103, 1213–1269; b) M. Rubin, M. Rubina, V.
Gevorgyan, Chem. Rev. 2007, 107, 3117–3179; c) H.
Pellissier, Tetrahedron 2010, 66, 8341–8375; d) A.
Ahmad, I. Marek, Chem. Eur. J. 2010, 16, 9712–9721;
for recent selected examples, see: e) F. Lꢃpez, A. Del-
gado, J. R. Rodrꢄguez, L. Castedo, J. L. MascareÇas, J.
Am. Chem. Soc. 2004, 126, 10262–10263; f) M. Gulꢄas,
Juan Durꢅn, F. Lꢃpez, L. Castedo, J. L. MascareÇas, J.
Am. Chem. Soc. 2007, 129, 11026–11027; g) J. Terao, M.
Tomita, S. P. Singh, N. Kambe, Angew. Chem. 2010,
122, 148–151; Angew. Chem. Int. Ed. 2010, 49, 144–147;
h) S. Saito, K. Maeda, R. Yamasaki, T. Kitamura, M.
Nakagawa, K. Kato, I. Azumaya, H. Masu, Angew.
Chem. 2010, 122, 1874–1877; Angew. Chem. Int. Ed.
2010, 49, 1830–1833; i) T. Inami, T. Kurahashi, S. Mat-
subara, Chem. Commun. 2011, 47, 9711–9713; j) A. P.
Evans, P. A. Inglesby, J. Am. Chem. Soc. 2012, 134,
3635–3638.
[3] Selected examples: a) J. R. Evans, E. J. Napier, R. A.
Fletton, J. Antibiot. 1978, 31, 952–958; b) T. Nemoto,
M. Ojika, Y. Sakagami, Tetrahedron Lett. 1997, 38,
5667–5670; c) T. Nemoto, G. Yoshino, M. Ojika, Y. Sa-
kagami, Tetrahedron 1997, 53, 16699–16710.
[4] a) J. Zemlicka, in: Recent Advances in Nucleosides:
Chemistry and Chemotherapy, (Ed.: C. K. Chu), Elsevi-
er Science, Amsterdam, 2002, pp 327–357; b) J. Zem-
licka, in: Advances in Antiviral Drug Design, (Ed.: E.
De Clercq), Elsevier, Amsterdam, 2007, pp 113–167.
[5] For relatively unconventional examples, see: a) J.
Montgomery, G. M. Wieber, L. S. Hegedus, J. Am.
Chem. Soc. 1990, 112, 6255–6263; b) A. T. McNichols,
P. J. Stang, D. M. Addington, Tetrahedron Lett. 1994,
35, 437–440; c) V. Nair, A. T. Biju, S. C. Mathew, Syn-
thesis 2007, 697–704.
[13] a) J. Bigeault, L. Giordano, G. Buono, Angew. Chem.
2005, 117, 4831–4835; Angew. Chem. Int. Ed. 2005, 44,
4753–4757; b) J. Bigeault, L. Giordano, I. De Riggi, Y.
Gimbert, G. Buono, Org. Lett. 2007, 9, 3567–3570; c) J.
Bigeault, I. De Riggi, Y. Gimbert, L. Giordano, G.
Buono, Synlett 2008, 1071–1075.
[14] The tricyclo[3.2.1.02,4]oct-6-ene structure is known to
rearrange into tetracyclo[3.3.0.02,8.04,6]octane following
either a photoinduced process, see: a) H. Prinzbach, W.
Eberbach, G. von Veh, Angew. Chem. 1965, 77, 454–
455; Angew. Chem. Int. Ed. Engl. 1965, 4, 436–437;
a thermal activation, see: b) D. Aue, H. M. J. Meshish-
nek, J. Am. Chem. Soc. 1977, 99, 223–231; c) J. Krebs,
D. Guggisberg, U. Stꢆmpfli, M. Neuenschwander, Helv.
Chim. Acta 1986, 69, 835–848; or a rhodium-promoted
pathway, see: d) H. C. Volger, H. Hogeveen, M. M. P.
Gaasbeek, J. Am. Chem. Soc. 1969, 91, 218–219; e) D.
Kaufmann, H.-H. Fick, O. Schallner, W. Spielmann, L.-
M. Meyer, P. Gçlitz, A. De Meijere, Chem. Ber. 1983,
116, 587–609.
[15] a) P. R. Khoury, J. D. Goddard, W. Tam, Tetrahedron
2004, 60, 8103–8112; b) M. Balci, M. Gꢇney, A. Dastan,
A. Azizoglu, J. Org. Chem. 2007, 72, 4756–4762.
[6] A. G. Cook, S. B. Herscher, D. J. Schultz, J. A. Burke, J.
[16] a) E. L. Eliel, S. H. Wilen, L. N. Mander, in: Stereo-
Org. Chem. 1970, 35, 1550–1554.
chemistry of Organic Compounds, Wiley, New York,
Adv. Synth. Catal. 2013, 355, 403 – 408
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
407